Details for Patent: 9,549,899
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,549,899 protect, and when does it expire?
Patent 9,549,899 protects ARYMO ER and is included in one NDA.
This patent has twelve patent family members in twelve countries.
Summary for Patent: 9,549,899
Title: | Abuse deterrent pharmaceutical compositions for controlled release |
Abstract: | The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain. |
Inventor(s): | Tygesen; Peter Holm (Vaerlose, DK), Lindhardt; Karsten (Haslev, DK), Olsen; Martin Rex (Holbaek, DK), Fischer; Gina Engslev (Vaerlose, DK), Overgard; Jan Martin (Frederikssund, DK), Boye; Georg (Hedehusene, DK), Skak; Nikolaj (Virum, DK), Elhauge; Torben (Copenhagen K, DK) |
Assignee: | EGALET LTD. (London, GB) |
Application Number: | 13/933,053 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,549,899 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 9,549,899
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-001 | Jan 9, 2017 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE | See Plans and Pricing | |||
Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-002 | Jan 9, 2017 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE | See Plans and Pricing | |||
Zyla | ARYMO ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603-003 | Jan 9, 2017 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,549,899
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Denmark | PA 2012 70405 | Jul 6, 2012 |
International Family Members for US Patent 9,549,899
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013285988 | See Plans and Pricing | |||
Brazil | 112015000150 | See Plans and Pricing | |||
Canada | 2877183 | See Plans and Pricing | |||
China | 104684548 | See Plans and Pricing | |||
Eurasian Patent Organization | 201590165 | See Plans and Pricing | |||
European Patent Office | 2877161 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |